# Discussing axSpA: Real-world outcomes for patients with axSpA receiving SC infliximab

Page: https://stenobird.com/podcast/the-imid-forum-981476/discussing-axspa-real-world-outcomes-for-patients-with-axspa-receiving-sc-infliximab
Text version: https://stenobird.com/podcast/the-imid-forum-981476/discussing-axspa-real-world-outcomes-for-patients-with-axspa-receiving-sc-infliximab.md
Podcast: [The IMID Forum](https://stenobird.com/podcast/the-imid-forum-981476)
Published: 2025-12-11T11:30:00+00:00
Episode link: https://soundcloud.com/imidforum/discussing-axspa-real-world-outcomes-for-patients-with-axspa-receiving-sc-infliximab
Audio file: https://feeds.soundcloud.com/stream/2227763981-imidforum-discussing-axspa-real-world-outcomes-for-patients-with-axspa-receiving-sc-infliximab.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/the-imid-forum-981476/episodes/discussing-axspa-real-world-outcomes-for-patients-with-axspa-receiving-sc-infliximab
Duration seconds: 788

## Resource

Join Dr Sofia Ramiro and Professor Xenofon Baraliakos as they discuss the top publications in the world of axSpA. This month, the conversation covered a retrospective, multinational, cross-sectional survey of real-world outcomes for patients with axial spondyloarthritis receiving subcutaneous infliximab

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/the-imid-forum-981476/episodes/discussing-axspa-real-world-outcomes-for-patients-with-axspa-receiving-sc-infliximab/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/the-imid-forum-981476/discussing-axspa-real-world-outcomes-for-patients-with-axspa-receiving-sc-infliximab.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.